Transfusion-associated circulatory overload in a pediatric patient with neuroblastoma.

[1]  S. Shimodaira,et al.  Factors related to allergic transfusion reactions and febrile non‐haemolytic transfusion reactions in children , 2016, Vox sanguinis.

[2]  A. Piccin,et al.  Transfusion‐associated circulatory overload in Ireland: a review of cases reported to the National Haemovigilance Office 2000 to 2010 , 2015, Transfusion.

[3]  Tomohiko Nakamura,et al.  Pretransplant‐corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation , 2015, Transplant international : official journal of the European Society for Organ Transplantation.

[4]  M. Popovsky,et al.  How we view and approach transfusion‐associated circulatory overload: pathogenesis, diagnosis, management, mitigation, and prevention , 2013, Transfusion.

[5]  H. Nakazawa,et al.  Impact of immunoreactive substances contained in apheresis platelet concentrate on postoperative respiratory function in surgical patients receiving platelet transfusion: a prospective cohort study , 2013, Transfusion medicine.

[6]  N. Blumberg,et al.  An association between decreased cardiopulmonary complications (transfusion‐related acute lung injury and transfusion‐associated circulatory overload) and implementation of universal leukoreduction of blood transfusions , 2010, Transfusion.

[7]  O. Gajic,et al.  The accuracy of natriuretic peptides (brain natriuretic peptide and N‐terminal pro‐brain natriuretic) in the differentiation between transfusion‐related acute lung injury and transfusion‐related circulatory overload in the critically ill , 2009, Transfusion.

[8]  L. Sokoll,et al.  N‐terminal pro‐brain natriuretic peptide is a useful diagnostic marker for transfusion‐associated circulatory overload , 2008, Transfusion.